project_name,project_description,primary_disease,study_name,longitudinal,study_description
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Parkinson's Disease Demo Dataset,1,Subjects with a diagnosis of PD for two years or less who are not taking PD medications.
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Healthy Control Demo Dataset,1,Control Subjects without PD who are 30 years or older and who do not have a first degree blood relative with PD.
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,SWEDD Demo Dataset,1,Subjects consented as PD subjects who have DaTscans that do not show evidence of a dopaminergic deficit.
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Prodromal Demo Dataset,1,Subjects without Parkinson's disease who have a diagnosis of hyposmia or REM sleep behavior disorder (RBD).
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Genetic Cohort Demo Dataset,1,"Subjects with and without Parkinson's disease who have a genetic mutation in LRRK2, GBA, or SNCA."
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Genetic Registry Demo Dataset,1,"Subjects with and without Parkinson's disease who have a genetic mutation in LRRK2, GBA, or SNCA or a first-degree relative with a LRRK2, GBA, or SNCA mutation who are evaluated at less frequent intervals to augment and broaden the follow-up of PD subjects and family members with PD associated mutations ."
PPMI Demo Dataset,"The Parkinson's Progression Markers Initiative (PPMI) is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest using advanced imaging, biologic sampling and clinical and behavioral assessments to identify biomarkers of Parkinson's disease progression.",Parkinson's,Unknown Demo Dataset,1,Subjects for whom no study was assigned.